Across TCGA pan-cancer cohorts, KIF19 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of KIF19’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where KIF19 RNA is repressed in tumor relative to normal tissue. In most cancer types KIF19 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.
THCA, KIRC, and LUSC are the cancer types where KIF19 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KIF19 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.